Ally Bridge Group (NY) LLC

Holdings History for Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS)

Symbol: APLS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2024		-6.5%	$0	0	-150,000	-100%	$21.64	Q1 2024
31 Dec 2023	6.5%	-1.4%	$8,979,000	150,000	-31,805	-17%	$59.86	Q4 2023
30 Sep 2023	8.1%	+8.1%	$6,915,862	181,805	+181,805	NEW	$38.04	Q3 2023
30 Sep 2021		-1.5%	$0	0	-85,000	-100%	$21.64	Q3 2021
30 Jun 2021	1.5%	-2.6%	$5,372,000	85,000	-145,000	-63%	$63.20	Q2 2021
31 Mar 2021	2.4%	0%	$9,869,000	230,000	0		$42.91	Q1 2021
31 Dec 2020	3.4%	0%	$13,156,000	230,000	0		$57.20	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.